Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Psychopharmacology (Berl) ; 173(1-2): 79-87, 2004 Apr.
Article de Anglais | MEDLINE | ID: mdl-14712339

RÉSUMÉ

RATIONALE: During binocular rivalry, two incompatible images are presented to each eye and these monocular stimuli compete for perceptual dominance, with one pattern temporarily suppressed from awareness. One variant of stimulus presentation in binocular rivalry experiments is dichoptic stimulus alternation (DSA), when stimuli are applied to the eyes in rapid reversals. There is preliminary report that in contrast with healthy controls, schizophrenic patients can maintain binocular rivalry even at very high DSA rates. OBJECTIVE: The study was undertaken to investigate whether binocular rivalry survives high rates of DSA induced by the South American hallucinogenic beverage ayahuasca. METHODS: Ten individuals who were participating in ayahuasca ceremonials were requested to volunteer for binocular rivalry tests (DSA=0, 3.75, 7.5, 15 and 30 Hz) without and after drinking the brew. RESULTS: Ingestion of ayahuasca increased mean dominance periods both in standard binocular rivalry conditions (no DSA) and tests with DSA. At higher DSA rates (15 and 30 Hz) the total length of dominance periods was longer on the brew. CONCLUSION: It is discussed that ayahuasca-induced survival of binocular rivalry at high DSA rates may be related to slow visual processing and increased mean dominance periods may result from hallucinogen-induced alteration of gamma oscillations in the visual pathways.


Sujet(s)
Banisteriopsis/composition chimique , Hallucinogènes/effets indésirables , Disparité rétinienne/effets des médicaments et des substances chimiques , Vision binoculaire/effets des médicaments et des substances chimiques , Perception visuelle/effets des médicaments et des substances chimiques , Adulte , Sujet âgé , Femelle , Hallucinogènes/pharmacologie , Harmine/effets indésirables , Harmine/pharmacologie , Humains , Mâle , Adulte d'âge moyen , Stimulation lumineuse/méthodes , Extraits de plantes/pharmacologie , Performance psychomotrice/effets des médicaments et des substances chimiques , Disparité rétinienne/physiologie , Vision binoculaire/physiologie , Perception visuelle/physiologie
2.
Food Addit Contam ; 19(7): 671-5, 2002 Jul.
Article de Anglais | MEDLINE | ID: mdl-12113662

RÉSUMÉ

The occurrence of aflatoxins and fumonisins in Incaparina was investigated. Incaparina is a mixture of corn and cottonseed flour with added vitamins, minerals and a preservative. It has been marketed as a high-protein food supplement, particularly for children on protein-deficient diets. According to estimates, 80% of Guatemalan children in their first year are given Incaparina to provide an adequate diet. Eight samples of Incaparina manufactured in Guatemala were collected. Five were from three different geographical locations in the USA and three were from Guatemala. Seven were examined for fungal contamination and analysed for aflatoxins and fumonisins. Aspergillus flavus was the predominant fungus in all samples purchased in the USA and in one sample purchased from Guatemala, whereas Fusarium verticillioides was present in only two samples (one from the USA and one from Guatemala). All samples contained aflatoxins, ranging from 3 to 214 ng g(-1) and <2 to 32ng g(-1) for aflatoxin B(1) and aflatoxin B(2), respectively; and one sample contained aflatoxin G(1) (7 ng g(-1)). Total aflatoxins present ranged from 3 to 244 ng g(1). All samples contained fumonisins, ranging from 0.2 to 1.7 microg g(-1), <0.1 to 0.6 microg g(-1), and <0.1 to 0.2 microg g(-1) for fumonisins B(1), fumonisin B(2), and fumonisin B(2), respectively. Total fumonisins present ranged from 0.2 to 2.2 microg g(-1). The identity of aflatoxin B(2) was confirmed using both the chemical derivatization method and liquid chromatographic (LC)/mass spectrometric (MS) analysis. Appropriate regulatory action was recommended for the import of Incaparina and has been in effect since 22 December 1998.


Sujet(s)
Aflatoxines/analyse , Compléments alimentaires/analyse , Contamination des aliments/analyse , Fumonisines , Mycotoxines/analyse , Aspergillus flavus/isolement et purification , Acides carboxyliques/analyse , Compléments alimentaires/microbiologie , Champignons/isolement et purification , Guatemala , Humains
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE